Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Le Page

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Revue Neurologique|September 24, 2008
[Use of mitoxantrone in early multiple sclerosis with malignant disease course. Observational study in 30 patients with clinical and MRI outcomes after one year]S Ory, M Debouverie, E Le Page, et al.
Revue Neurologique|February 19, 2022
Ten-year follow-up after mitoxantrone induction for early highly active relapsing-remitting multiple sclerosis: An observational study of 100 consecutive patientsM Lefort, G Le Corre, E Le Page, et al.
Revue Neurologique|October 2, 2021
Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trialM Michel, E Le Page, D A Laplaud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosisR G Ghalie, E Mauch, G Edan, et al.
Journal of the Neurological Sciences|June 14, 2011
Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patientsA Kerbrat, E Le Page, E Leray, et al.
Journal of Neurology|September 9, 2020
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosisF Lejeune, A Chatton, D-A Laplaud, et al.
Journal of Neurology|July 29, 2018
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patientsG Balloy, J Pelletier, L Suchet, et al.
Neurology|March 3, 2010
Neuromyelitis optica in France: a multicenter study of 125 patientsN Collongues, R Marignier, H Zéphir, et al.
Neurology|April 13, 2005
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severityR H S R Roxburgh, S R Seaman, T Masterman, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Revue Neurologique|September 24, 2008
[Use of mitoxantrone in early multiple sclerosis with malignant disease course. Observational study in 30 patients with clinical and MRI outcomes after one year]S Ory, M Debouverie, E Le Page, et al.
Revue Neurologique|February 19, 2022
Ten-year follow-up after mitoxantrone induction for early highly active relapsing-remitting multiple sclerosis: An observational study of 100 consecutive patientsM Lefort, G Le Corre, E Le Page, et al.
Revue Neurologique|October 2, 2021
Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trialM Michel, E Le Page, D A Laplaud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosisR G Ghalie, E Mauch, G Edan, et al.
Journal of the Neurological Sciences|June 14, 2011
Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patientsA Kerbrat, E Le Page, E Leray, et al.
Journal of Neurology|September 9, 2020
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosisF Lejeune, A Chatton, D-A Laplaud, et al.
Journal of Neurology|July 29, 2018
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patientsG Balloy, J Pelletier, L Suchet, et al.
Neurology|March 3, 2010
Neuromyelitis optica in France: a multicenter study of 125 patientsN Collongues, R Marignier, H Zéphir, et al.
Neurology|April 13, 2005
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severityR H S R Roxburgh, S R Seaman, T Masterman, et al.
Pageof 3